These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 25292315)

  • 1. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.
    Zhang X; Song Z; Guo Y; Zhou M
    Mol Cell Biochem; 2015 Jan; 399(1-2):155-65. PubMed ID: 25292315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PI3K/p-Akt signaling pathway participates in calcitriol ameliorating podocyte injury in DN rats.
    Song Z; Guo Y; Zhou M; Zhang X
    Metabolism; 2014 Oct; 63(10):1324-33. PubMed ID: 25044177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
    Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
    Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy.
    Ma R; Wang Y; Xu Y; Wang R; Wang X; Yu N; Li M; Zhou Y
    J Diabetes Res; 2021; 2021():8832114. PubMed ID: 34095318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression.
    Ma R; Liu L; Jiang W; Yu Y; Song H
    Int J Clin Exp Pathol; 2015; 8(11):14063-74. PubMed ID: 26823720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
    Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D prevents podocyte injury via regulation of macrophage M1/M2 phenotype in diabetic nephropathy rats.
    Zhang XL; Guo YF; Song ZX; Zhou M
    Endocrinology; 2014 Dec; 155(12):4939-50. PubMed ID: 25188527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
    Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
    Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panax Notoginseng Ameliorates Podocyte EMT by Targeting the Wnt/β-Catenin Signaling Pathway in STZ-Induced Diabetic Rats.
    Xie L; Zhai R; Chen T; Gao C; Xue R; Wang N; Wang J; Xu Y; Gui D
    Drug Des Devel Ther; 2020; 14():527-538. PubMed ID: 32103895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of podocyte-secreted angiopoietin-like-4 in diabetic nephropathy.
    Ma J; Chen X; Li JS; Peng L; Wei SY; Zhao SL; Li T; Zhu D; He YX; Wei QJ; Li B
    Endocrine; 2015 Jun; 49(2):373-84. PubMed ID: 25424436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
    Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragalus membranaceus and Panax notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats.
    Zhai R; Jian G; Chen T; Xie L; Xue R; Gao C; Wang N; Xu Y; Gui D
    J Diabetes Res; 2019; 2019():1602892. PubMed ID: 31179338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy.
    Cheng Q; Pan J; Zhou ZL; Yin F; Xie HY; Chen PP; Li JY; Zheng PQ; Zhou L; Zhang W; Liu J; Lu LM
    Acta Pharmacol Sin; 2021 Jun; 42(6):954-963. PubMed ID: 32968210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
    Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
    J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Therapeutic Effect of Active Vitamin D Supplementation in Preventing the Progression of Diabetic Nephropathy in a Diabetic Mouse Model.
    Nakhoul N; Thawko T; Farber E; Dahan I; Tadmor H; Nakhoul R; Hanut A; Salameh G; Shagrawy I; Nakhoul F
    J Diabetes Res; 2020; 2020():7907605. PubMed ID: 33294462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D/vitamin D receptor/Atg16L1 axis maintains podocyte autophagy and survival in diabetic kidney disease.
    Shi L; Xiao C; Zhang Y; Xia Y; Zha H; Zhu J; Song Z
    Ren Fail; 2022 Dec; 44(1):694-705. PubMed ID: 35469547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reno-protective effect of a phosphoinositide 3-kinase inhibitor wortmannin on streptozotocin-induced proteinuric renal disease rats.
    Kim SH; Jang YW; Hwang P; Kim HJ; Han GY; Kim CW
    Exp Mol Med; 2012 Jan; 44(1):45-51. PubMed ID: 22056625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.
    Zhang J; Fu H; Xu Y; Niu Y; An X
    J Nat Med; 2016 Oct; 70(4):740-8. PubMed ID: 27255369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of Trpc6 knockout in the progression of diabetic kidney disease.
    Spires D; Ilatovskaya DV; Levchenko V; North PE; Geurts AM; Palygin O; Staruschenko A
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1091-F1097. PubMed ID: 29923767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of angiotensin II receptor antagonist on rat podocyte injury in early diabetic nephropathy].
    Long HB; Zhong J; Wei LB; Zhou WD; Xu ZZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):505-8. PubMed ID: 17545045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.